Should You Buy ADMA Biologics Inc (ADMA) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
Not a good buy right now for a beginner long-term investor who is impatient. Despite improving fundamentals and strong hedge-fund accumulation, the price trend is still decisively bearish (bearish MA stack, weakening MACD) and the near-term pattern stats point to further downside over the next week/month. I would not initiate a new position until the stock at least reclaims key support (~16.71) and starts basing; otherwise risk/reward is unfavorable at this moment.
Technical Analysis
Trend is bearish and weakening: SMA_200 > SMA_20 > SMA_5 confirms a sustained downtrend, and the MACD histogram (-0.156) is below zero and expanding negatively (momentum still deteriorating). RSI_6 at ~27.7 indicates the stock is short-term oversold, but oversold alone is not a buy signal when momentum is still worsening. Levels: price ~16.55 is below S1 (16.712) and above S2 (16.285); failure to regain 16.71 keeps pressure toward 16.29, while any rebound faces resistance near the pivot 17.404 then 18.095. Intellectia Proprietary Trading Signals: - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently. Pattern-based expectation provided: ~-8.55% next week and ~-14.04% next month, aligning with the bearish technical setup.
Analyst Ratings and Price Target Trends
No analyst rating trend or price-target change data was provided, so a Wall Street consensus shift cannot be confirmed from the dataset. From the data available, the ‘pro’ case is improving margins and institutional buying; the ‘con’ case is the still-deteriorating technical trend and lack of near-term catalysts.
Wall Street analysts forecast ADMA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ADMA is 30 USD with a low forecast of 30 USD and a high forecast of 30 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast ADMA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ADMA is 30 USD with a low forecast of 30 USD and a high forecast of 30 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 17.010
Current: 17.010
